In this video, Geoffrey Shouse, DO, PhD, City of Hope Comprehensive Cancer Center, Duarte, CA, shares some insights into a Phase I study evaluating copanlisib in combination with nivolumab in patients with Richter’s transformation (RT) or transformed non-Hodgkin lymphoma (tNHL; NCT03884998). This interview took place at the 64th ASH Annual Meeting and Exposition congress in New Orleans, LA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.